Immunopharmacology logo Elsevier logo

Publisher: Elsevier

Volume 34, Number 1, August 1996
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Recombinant human prolactin induces protection against Salmonella typhimurium infection in the mouse: role of nitric oxide
pp. 1-7(7)
Authors: Pattie D.C.; Snyder J.; Meli R.; Raso G.M.; Bentivoglio C.; Nuzzo I.; Galdiero M.; Di Carlo R.

Mirfentanil antagonizes morphine-induced suppression of splenic NK activity in mice
pp. 9-16(8)
Authors: Carr D.J.J.; Brockunier L.L.; Scott M.; Bagley J.R.; France C.P.

Immunomodulating and articular protecting activities of a new anti-rheumatic drug, TAK-603
pp. 17-26(10)
Authors: Ohta Y.; Fukuda S.; Baba A.; Nagai H.; Tsukuda R.; Sohda T.; Makino H.

Facilitation of apoptosis by autologous serum and related immunosuppression in the splenocyte culture
pp. 39-50(12)
Authors: Hwan M.K.; Goo T.O.; Dong H.H.; Byung H.H.; Young N.C.; Byung S.Y.; Sang B.H.

Dexamethasone inhibits nitric oxide-mediated cytotoxicity via effects on both macrophages and target cells
pp. 71-71(1)
Authors: Brohman J.; Yuai L.; Ito N.; Suzuki T.; Stechschulte D.J.; Dileepan K.N.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A